• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations.

作者信息

Shiraishi T, Muneyuki T, Fukutome K, Ito H, Kotake T, Watanabe M, Yatani R

机构信息

Second Department of Pathology, Mie University School of Medicine, Japan.

出版信息

Anticancer Res. 1998 Jul-Aug;18(4B):2789-92.

PMID:9713462
Abstract

Point mutations of the ras gene family are thought to be involved in the development of a variety of human tumors. However, it remains unknown whether the ras gene might play a key role in prostate carcinogenesis. We therefore analysed Ki-,N- and H-ras gene mutations in a series of 81 Japanese prostate cancers using PCR-SSCP analysis and Mutant-Allele-Specific Amplification (MASA) method. Mutated as genes were detected in 20 of the 81 samples (24%); three of 22 latent, one of five stage B, four of 14 stage C and 12 of 40 stage D cancers. Of the twenty as gene mutations, 13 were in Ki-ras (codon 12), five in H-ras codon 61 and two H-ras codon 13. The observed frequency of ras gene mutations was higher than that reported in the literature for some non-Japanese prostate cancers, suggesting the possibility of genetic differences between populations.

摘要

相似文献

1
Mutations of ras genes are relatively frequent in Japanese prostate cancers: pointing to genetic differences between populations.
Anticancer Res. 1998 Jul-Aug;18(4B):2789-92.
2
Presence of ras oncogene mutations and human papillomavirus DNA in human prostate carcinomas.人类前列腺癌中ras癌基因突变和人乳头瘤病毒DNA的存在情况。
Cancer Res. 1992 Nov 1;52(21):5991-6.
3
ras gene mutations in human prostate cancer.人类前列腺癌中的ras基因突变。
Cancer Res. 1990 Nov 1;50(21):6830-2.
4
Detection of ras gene mutations in human lung cancers by single-strand conformation polymorphism analysis of polymerase chain reaction products.通过聚合酶链反应产物的单链构象多态性分析检测人肺癌中的ras基因突变。
Oncogene. 1990 Jul;5(7):1037-43.
5
Mutations in the p53 and Ki-ras genes, microsatellite instability and site of tumor origin in colorectal cancer.p53和Ki-ras基因的突变、微卫星不稳定性与结直肠癌的肿瘤起源部位
Oncol Rep. 2005 Sep;14(3):625-31.
6
Mutations of K-ras oncogene and absence of H-ras mutations in squamous cell carcinomas of the lung.肺鳞状细胞癌中K-ras癌基因的突变及H-ras突变的缺失
Clin Cancer Res. 1995 Mar;1(3):359-65.
7
Expression status and mutational analysis of the ras and B-raf genes in ovarian granulosa cell and epithelial tumors.卵巢颗粒细胞瘤和上皮性肿瘤中ras和B-raf基因的表达状态及突变分析
Gynecol Oncol. 2004 Dec;95(3):603-9. doi: 10.1016/j.ygyno.2004.07.062.
8
Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.散发性原发性黑色素瘤中BRAF和N-Ras激活突变:与9号染色体上等位基因缺失呈负相关。
Oncogene. 2003 Dec 18;22(58):9217-24. doi: 10.1038/sj.onc.1206909.
9
Detection of point mutations at codon 12 of KI-ras in ophthalmic pterygia.
Eye (Lond). 2005 Feb;19(2):210-4. doi: 10.1038/sj.eye.6701452.
10
Usefulness of p53 gene mutations in the supernatant of bile for diagnosis of biliary tract carcinoma: comparison with K- ras mutation.胆汁上清液中p53基因突变对胆道癌诊断的价值:与K-ras基因突变的比较
J Gastroenterol. 2002;37(10):831-9. doi: 10.1007/s005350200137.

引用本文的文献

1
Prostate cancer stem cells: deciphering the origins and pathways involved in prostate tumorigenesis and aggression.前列腺癌干细胞:解读前列腺肿瘤发生和侵袭的起源及相关途径。
Oncotarget. 2015 Feb 10;6(4):1900-19. doi: 10.18632/oncotarget.2953.
2
MicroRNA-34a regulates WNT/TCF7 signaling and inhibits bone metastasis in Ras-activated prostate cancer.微小RNA-34a调控WNT/TCF7信号通路并抑制Ras激活的前列腺癌的骨转移。
Oncotarget. 2015 Jan 1;6(1):441-57. doi: 10.18632/oncotarget.2690.
3
Loss of EGFR signaling regulated miR-203 promotes prostate cancer bone metastasis and tyrosine kinase inhibitors resistance.
表皮生长因子受体(EGFR)信号调控的miR-203缺失促进前列腺癌骨转移及对酪氨酸激酶抑制剂耐药。
Oncotarget. 2014 Jun 15;5(11):3770-84. doi: 10.18632/oncotarget.1994.
4
Mutation status of somatic EGFR and KRAS genes in Chinese patients with prostate cancer (PCa).中国前列腺癌(PCa)患者体细胞 EGFR 和 KRAS 基因突变状态。
Virchows Arch. 2014 May;464(5):575-81. doi: 10.1007/s00428-014-1566-x. Epub 2014 Mar 5.
5
The molecular basis for ethnic variation and histological subtype differences in prostate cancer.前列腺癌的种族变异和组织学亚型差异的分子基础。
Sci China Life Sci. 2013 Sep;56(9):780-7. doi: 10.1007/s11427-013-4522-0. Epub 2013 Jul 13.
6
AKT upregulates B-Raf Ser445 phosphorylation and ERK1/2 activation in prostate cancer cells in response to androgen depletion.AKT 上调前列腺癌细胞中 B-Raf Ser445 的磷酸化和 ERK1/2 的激活,以应对雄激素耗竭。
Exp Cell Res. 2013 Jul 15;319(12):1732-1743. doi: 10.1016/j.yexcr.2013.05.008. Epub 2013 May 20.
7
The Raf/MEK/extracellular signal-regulated kinase 1/2 pathway can mediate growth inhibitory and differentiation signaling via androgen receptor downregulation in prostate cancer cells.Raf/MEK/细胞外信号调节激酶 1/2 通路可通过下调前列腺癌细胞中的雄激素受体来介导生长抑制和分化信号。
Exp Cell Res. 2011 Nov 1;317(18):2671-82. doi: 10.1016/j.yexcr.2011.08.008. Epub 2011 Aug 16.
8
BRAF activation initiates but does not maintain invasive prostate adenocarcinoma.BRAF激活启动但不维持侵袭性前列腺腺癌。
PLoS One. 2008;3(12):e3949. doi: 10.1371/journal.pone.0003949. Epub 2008 Dec 16.
9
Behavioral genetics of the depression/cancer correlation: a look at the Ras oncogene family and the 'cerebral diabetes paradigm'.抑郁/癌症相关性的行为遗传学:审视Ras癌基因家族与“大脑糖尿病范式”。
J Mol Neurosci. 2008 Jul;35(3):307-22. doi: 10.1007/s12031-008-9078-2. Epub 2008 Jun 18.
10
The role of polycyclic aromatic hydrocarbon-DNA adducts in inducing mutations in mouse skin.多环芳烃-DNA加合物在诱导小鼠皮肤突变中的作用。
Mutat Res. 2008 Jan 8;649(1-2):161-78. doi: 10.1016/j.mrgentox.2007.08.007. Epub 2007 Sep 7.